30-Day Survival After Temporary Right Ventricular Assist Devices: A Systematic Review | ||||
| Cardiovascular Research Prove Journal | ||||
| Volume 6, Issue 1, June 2022 PDF (200.14 K) | ||||
| Document Type: Abstracts | ||||
| DOI: 10.21608/cvrepj.2022.351455 | ||||
 View on SCiNiTO | ||||
| Abstract | ||||
| Acute right-sided heart failure (RHF) is a complex clinical syndrome, with a wide range of clinical presentations, associated with increased mortality and morbidity, but with a scarcity of evidence-based literature. Temporary right ventricular assist device (t-RVAD) is a potential treatment option for selected patients with severe right ventricular dysfunction as a bridge-to-recovery or as a permanent solution. | ||||
|
Statistics Article View: 66 PDF Download: 29 |
||||
